We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




fMRI Reveals Insights into Brains of People With Borderline Personality Disorder

By HospiMedica International staff writers
Posted on 29 Sep 2008
In a game of give and receive, the brains of individuals with borderline personality disorder frequently do not understand the underlying strategy. More...
In fact, an interactive economic game played between two individuals placed in functional magnetic resonance imaging (fMRI) machines revealed a brain malfunction associated with the disorder, a debilitating but common mental illness that affects an individual's perceptions of the world and other people, according to the study's investigators.

"This may be the first time a physical signature for a personality disorder has been identified,” said Dr. P. Read Montague, professor of neuroscience at Baylor College of Medicine and director of the Baylor College of Medicine (BCM; Houston, TX, USA) Brown Foundation Human Neuroimaging Laboratory.

In the study, which was published in the August 8, 2008, issue of the journal Science, directed by Dr. Brooks King-Casas, assistant professor of neuroscience and psychiatry and behavioral sciences at BCM and a member of the College's new Computational Psychiatry Unit, 55 people with borderline personality disorder played a "trust” game with 55 normal individuals of the same age and social and educational status.

In the game, one player called an investor sends US$20 to the other called a trustee. The investment is tripled, and the trustee divides the profits with the investor. The trustee decides how much to send back, thus determining whether the investor recovers a profit or not. Profit requires cooperation between trustee and investor. Both investor and trustee play the game while their brains are scanned by functional MRI devices through use of software called hyperscanning. The fMRI shows areas of blood flow in parts of the brain during the interaction between two people.

In this study, activity in a region of the brain called the anterior insula, known to respond when "norms” are violated, showed up on the scans. In the normal people, the anterior insula showed activity that responded in direct proportion to the amount of money sent and the money received. However, in people with borderline personality disorder, that area of the brain responded only to sending the money--not to the money received.

The scan provides new insights into the neurobiology of borderline personality disorder, according to Dr. King-Casas, the study's lead author. Some day, he reported, it could be used as a diagnostic tool or even a way to determine the effectiveness of a treatment.

"For the first time, to my knowledge, we have a specific brain association for people with a personality disorder,” said Dr. Stuart Yudofsky, chair of the Menninger Department of Psychiatry and Behavioral Sciences at BCM. "It's new and different because it's not a lesion [or injury to the brain] but it is a difference in perceiving information that comes from an interaction.” That is the area where individuals with borderline personality disorder have the most problem.

People with borderline personality disorder suffer from an inability to understand the actions of others. They frequently have unstable relationships, fly into rages inappropriately, or become depressed and cannot trust the actions and motives of other people. "It's important that this biological signature has been identified,” said Dr. King-Casas. "It's not just a matter of bad attitudes or a lack of will.”

Dr. Yudofsky agreed that the finding might help eliminate the stigma associated with such disorders. The finding should help in three areas: (1) Diagnosis by giving a biologic measure that can be used to determine if a person has the problem. (2) Treatment using this brain-based difference to devise cognitive interventions or even medications that will affect the brain reactions. (3) Monitoring the effectiveness of treatment by determining how the brain's dysfunctional responses to the input from others change with treatment.

Related Links:

Baylor College of Medicine



Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Vessel Sealing Instrument
ERGOseal
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.